(Total Views: 245)
Posted On: 09/04/2020 7:47:15 AM
Post# of 107165
$RLFTF Relief Appoints Gilles Della Corte, M.D. as Chief Medical Officer Geneva, Switzerland, September 04, 2020
– RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief” or the “Company“), a biopharmaceutical company with its lead compound aviptadil in advanced clinical development to treat severe COVID-19 patients, today announced the appointment of Gilles Della Corte, M.D., as Chief Medical Officer, effective immediately.
https://relieftherapeutics.com/relief-appoint...l-officer/
– RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief” or the “Company“), a biopharmaceutical company with its lead compound aviptadil in advanced clinical development to treat severe COVID-19 patients, today announced the appointment of Gilles Della Corte, M.D., as Chief Medical Officer, effective immediately.
https://relieftherapeutics.com/relief-appoint...l-officer/
(0)
(0)
$MJ
